Cysteamine Bitartrate Suppliers & Bulk Manufacturers
Available Forms: Capsules / Eye Drop
Available Strengths: 25mg,50 mg, 75mg, 150 mg
Reference Brands: Cystagon (USA/EU), Procysbi(USA/EU), Cystadrops (EU/UK)
Category:
Nephrology
Cysteamine is a medication used to reduce cystine accumulation in cells, particularly in patients with nephropathic cystinosis, a rare genetic disorder. By decreasing cystine levels, it helps prevent kidney damage and other complications. It is available in oral and ophthalmic forms for systemic and eye-related management of the disease.
Cysteamine bitartrate is available in Capsules / Eye Drop
and strengths such as 25mg,50 mg, 75mg, 150 mg.
Sourced from GMP-certified and ISO-compliant manufacturers, this API meets
global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical
formulation and commercial manufacturing, Cysteamine bitartrate is supplied in
bulk quantities with complete regulatory support including DMF, COA, and MSDS.
|
Technical Specifications & Supply Details
|
| Lead Time |
7 to 60 days (depending on batch size & schedule) |
| MOQ |
As per manufacturer’s batch size |
| COA |
Available with every batch |
| Regulatory Dossier / DMF |
Available upon request |
| Export Documentation |
FSC, COA, Manufacturing License, Product Permission |
| Standards |
IP, BP, USP |
| Certifications |
WHO-GMP, EU-GMP, USFDA (as applicable) |
Cysteamine bitartrate can be exported to over 30 countries across Asia, Africa, Europe,
and Latin America. Flexible packaging, competitive pricing, and a verified supplier
network make Pharmatradz a trusted sourcing partner for pharmaceutical companies
and contract manufacturers worldwide.
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing